Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.00
+0.14 (1.29%)
At close: Aug 13, 2025, 4:00 PM
11.41
+0.41 (3.73%)
Pre-market: Aug 14, 2025, 9:25 AM EDT

Intellia Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
52.8657.8836.2852.1233.0557.99
Upgrade
Revenue Growth (YoY)
14.99%59.55%-30.40%57.69%-43.01%34.55%
Upgrade
Cost of Revenue
440.1466.31435.07419.98229.81150.41
Upgrade
Gross Profit
-387.25-408.43-398.79-367.86-196.75-92.41
Upgrade
Selling, General & Admin
124.77125.83116.590.3171.144.17
Upgrade
Operating Expenses
124.77125.83116.590.3171.144.17
Upgrade
Operating Income
-512.02-534.26-515.29-458.16-267.85-136.58
Upgrade
Interest & Investment Income
38.7647.8149.838.541.282.35
Upgrade
Earnings From Equity Investments
---15.63-11.08-1.33-
Upgrade
EBT Excluding Unusual Items
-473.26-486.46-481.09-460.7-267.89-134.23
Upgrade
Gain (Loss) on Sale of Investments
-6.93-32.57----
Upgrade
Other Unusual Items
---0.1-13.49--
Upgrade
Pretax Income
-480.19-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income
-480.19-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income to Common
-480.19-519.02-481.19-474.19-267.89-134.23
Upgrade
Shares Outstanding (Basic)
1039989777156
Upgrade
Shares Outstanding (Diluted)
1039989777156
Upgrade
Shares Change (YoY)
10.38%11.35%15.33%8.57%26.63%18.50%
Upgrade
EPS (Basic)
-4.68-5.25-5.42-6.16-3.78-2.40
Upgrade
EPS (Diluted)
-4.68-5.25-5.42-6.16-3.78-2.40
Upgrade
Free Cash Flow
-421.82-354.66-408.07-346.85-237.79-53.5
Upgrade
Free Cash Flow Per Share
-4.11-3.59-4.60-4.51-3.35-0.96
Upgrade
Gross Margin
------159.35%
Upgrade
Operating Margin
-968.69%-923.10%-1420.51%-879.04%-810.37%-235.51%
Upgrade
Profit Margin
-908.48%-896.77%-1326.51%-909.78%-810.49%-231.46%
Upgrade
Free Cash Flow Margin
-798.04%-612.78%-1124.94%-665.46%-719.41%-92.25%
Upgrade
EBITDA
-501.87-523.98-506.32-450.59-260.96-130.27
Upgrade
EBITDA Margin
------224.63%
Upgrade
D&A For EBITDA
10.1510.298.987.576.896.31
Upgrade
EBIT
-512.02-534.26-515.29-458.16-267.85-136.58
Upgrade
EBIT Margin
------235.51%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q